All News

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

October 1st 2025, 3:00pm

The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones.

Understanding the Evolving Role of a Pathologist in Lung Cancer Care

October 1st 2025, 1:00pm

Dr. Mary B. Beasley discusses evolving role of pathologists in lung cancer care, highlighting how emerging technologies may shape the future of the field.

Safe Food Practices at Home for Immunocompromised Patients With Cancer

September 30th 2025, 9:00pm

Heather Ann Yonker expands on strategies for maintaining food safety in the home, particularly for patients with compromised immune systems due to cancer.

Positive Experience With TAR-200 for Recurrent Bladder Cancer

September 30th 2025, 8:00pm

Frank Garred, 77, completed Inlexzo treatment for recurrent bladder cancer, describing it as manageable with minimal side effects compared with BCG.

Acupressure May Relieve Nausea, Vomiting for Patients With Cancer

September 30th 2025, 7:00pm

For patients with cancer grappling with nausea or vomiting due to their treatments, a potential side effect remedy may be found in their own hands.

I No Longer Think About Cancer Every Day

September 30th 2025, 5:00pm

New Strategy May Prevent Breast Cancer Relapse

September 30th 2025, 4:00pm

Penn Medicine researchers found two oral drugs eliminated dormant breast cancer cells in most patients, with relapse rates dropping to about 4% after seven years.

Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea

September 30th 2025, 3:00pm

Napo Pharmaceuticals applied for orphan drug designation for Mytesi to treat diarrhea in patients with breast cancer and brain metastases on targeted therapy.

Combination Therapies May Improve Survival in EGFR+ Lung Cancer

September 30th 2025, 1:00pm

Dr. Edgardo Santos explains that combining Tagrisso with chemotherapy or Leclaza plus Rybrevant may improve survival versus monotherapy alone.

Photobiomodulation Device Cuts Oral Mucositis in Head and Neck Cancer

September 29th 2025, 9:00pm

An LED-based intraoral device was safe and reduced severe oral mucositis and throat pain in patients receiving radiotherapy for head and neck cancers.